Effect of dexamethasone-eluting stents on systemic inflammatory response in patients with unstable angina pectoris or recent myocardial infarction undergoing percutaneous coronary intervention

Am J Cardiol. 2005 Feb 15;95(4):502-5. doi: 10.1016/j.amjcard.2004.10.021.

Abstract

The effect of treatment with steroid-eluting stents on systemic inflammatory response was investigated in patients with unstable angina pectoris or recent myocardial infarction who underwent percutaneous intervention. Compared with controls, dexamethasone-eluting stents significantly reduced C-reactive protein peak levels 48 hours after the procedure; this effect persisted for 7 days and was particularly evident in patients with elevated (>/=3 mg/L) preprocedural C-reactive protein values. Patients receiving a dexamethasone-eluting stent had lower adverse events during follow-up.

MeSH terms

  • Angina Pectoris / blood
  • Angina Pectoris / mortality
  • Angina Pectoris / therapy
  • Angioplasty, Balloon, Coronary
  • Anti-Inflammatory Agents / administration & dosage*
  • Biomarkers / blood
  • C-Reactive Protein / analysis*
  • Case-Control Studies
  • Coronary Artery Disease / blood
  • Coronary Artery Disease / mortality
  • Coronary Artery Disease / therapy
  • Dexamethasone / administration & dosage*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction / blood
  • Myocardial Infarction / mortality
  • Myocardial Infarction / therapy
  • Prospective Studies
  • Stents*

Substances

  • Anti-Inflammatory Agents
  • Biomarkers
  • Dexamethasone
  • C-Reactive Protein